Born into a farmer’s family, PP Reddy founded MEIL in 1989, starting with a small pipe manufacturing unit. The company has since expanded into large-scale projects such as dams, power plants, roads, and gas networks. MEIL built the world’s largest lift irrigation project, Kaleshwaram, and also manufactures electric buses under the Olectra brand in collaboration with China’s BYD. In 2024 alone, it secured orders for over 7,600 electric buses. The Reddy family’s net worth is estimated at $4.5 billion (Rs 40,000 crore).
B. Parthasaradhi Reddy, chairman of Hetero Group, founded the company in 1993. Today, it produces more than 200 pharmaceutical products, including medicines for AIDS, cancer, and diabetes. Reddy, who also serves as a Rajya Sabha MP representing the BRS party, has an estimated net worth of $3.95 billion (₹34,000 crore). (Photo: Siasat)
PV Ramprasad Reddy, co-founder of Aurobindo Pharma, has a net worth of $3.9 billion (₹34,000 crore). Founded in 1986 with a small plant in Puducherry, the company now exports to the U.S. and Europe, producing medicines for diabetes, heart diseases, and other conditions. In 2023, Aurobindo received approval to launch Revlimid, a cancer drug, in India — a major milestone for its oncology portfolio.
Surender Saluja founded Premier Energies, a Hyderabad-based solar power company, now run by his son Chiranjeev Saluja. In September 2024, the company’s IPO debuted at over 120% above its issue price, signaling strong investor confidence in India’s renewable energy sector. Saluja’s estimated net worth stands at $3.7 billion (Rs 32,000 crore).
Founded in 1984 by Dr. K Anji Reddy, Dr. Reddy’s Laboratories is now managed by his son Satish Reddy and son-in-law GV Prasad. The global pharmaceutical major has expanded into nutraceuticals, gene therapy, and digital healthcare, with most of its revenue coming from North America. The family’s combined net worth is $3.67 billion (Rs 31,500 crore).
Mahima Datla heads Biological E, one of India’s oldest vaccine makers, founded in 1953 in Hyderabad. The company developed Corbevax, a Covid-19 vaccine, and manufactures several WHO-approved vaccines exported to over 130 countries. Datla’s net worth is estimated at $3.3 billion (Rs 29,000 crore), placing her among India’s richest women entrepreneurs.
